https://www.selleckchem.com/pr....oducts/4-aminobutyri
6 (95% CI 8.7 to 20.2; n=28), and Clinician Global Assessment Score (CGAS) mean score increased from 52.3 to 69.8, difference 18.0 (95% CI 11.9 to 24.2; n=29). Of the 33 YP who participated in therapy, 12 (36%) recovered and were discharged. This programme demonstrated preliminary evidence for effectiveness and utility. Less specialised staff were able to use BA, and this may reduce secondary waits for more specialist therapy. More research is needed about the role of BA in specialist CAMHS. This programme demonstrated preli
Like
Comment
Share
